News | April 12, 2024
CRISPR-based innovations drive $21 billion in pharmaceutical licensing deals over five years, reveals GlobalData
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
A significant proportion of healthcare professionals still tend to favor branded drugs
ABRYSVO met its trial primary endpoints in adults aged 18 to 59 with an increased respiratory syncytial virus (RSV) disease risk.
Late-breaking data to be featured in an oral presentation at the American Association for Cancer Research (AACR) annual meeting on Monday, April 8 and highlighted as part of the official meeting press program
Fluid bed processes: drying, granulating, and coating in just one product container
Approximately half of all patients with metastatic breast cancer (mBC) express low levels of HER2
These observations are procedural in nature and will be responded within the stipulated time
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Empowering Research, Enhancing Proficiency is the theme of this year’s Homoeopathic Symposium
The observations are procedural in nature and will be responded to within the stipulated time
Subscribe To Our Newsletter & Stay Updated
